Earnings Feed
Start Free
|4Feb 8, 9:05 PM ET

Burak Eric 4

4 · Fusion Pharmaceuticals Inc. · Filed Feb 8, 2021

Insider Transaction Report

Form 4
Period: 2021-02-04
Fusion Pharmaceuticals Inc.FUSN
Burak Eric
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-04+139,000→ 139,000 total
    Exercise: $11.90Exp: 2031-02-03→ Common Stock (139,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-02-04+136,600→ 136,600 total
    Exercise: $11.90Exp: 2031-02-03→ Common Stock (136,600 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-02-04+41,000→ 41,000 total
    Exercise: $11.90Exp: 2031-02-03→ Common Stock (41,000 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on February 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
  • [F2]The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments beginning one month after the Transaction Date.
  • [F3]The shares subject to this option vest and become exercisable upon the achievement of certain manufacturing and development milestones; such milestones are expected to occur between December 2022 and December 2026.

Documents

2 files